Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kideok Jin

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
The Journal of Biological Chemistry|November 1, 2005
The survival kinase Mirk/dyrk1B is activated through Rac1-MKK3 signalingKideok Jin, Seunghwan Lim, Stephen E Mercer, et al.
Cancer Research|August 3, 2007
The survival kinase Mirk/Dyrk1B is a downstream effector of oncogenic K-ras in pancreatic cancerKideok Jin, Sunju Park, Daina Z Ewton, et al.
The Journal of Biological Chemistry|June 23, 2009
Mirk regulates the exit of colon cancer cells from quiescenceKideok Jin, Daina Z Ewton, Sunju Park, et al.
Experimental & Molecular Medicine|March 19, 2003
Metastasis-suppressor KAI1/CD82 induces homotypic aggregation of human prostate cancer cells through Src-dependent pathwayBokeun Jee, Kideok Jin, Jang-Hee Hahn, et al.
Nature Communications|September 3, 2014
Breast cancer cells condition lymphatic endothelial cells within pre-metastatic niches to promote metastasisEsak Lee, Elana J Fertig, Kideok Jin, et al.
The Journal of Biological Chemistry|June 12, 2002
The stress-activated protein kinases p38 alpha and JNK1 stabilize p21(Cip1) by phosphorylationGeum-Yi Kim, Stephen E Mercer, Daina Z Ewton, et al.
The Prostate|December 19, 2018
HOXB13 interaction with MEIS1 modifies proliferation and gene expression in prostate cancerDorhyun Johng, Gonzalo Torga, Charles M Ewing, et al.
Molecular Biology Reports|February 23, 2024
The role of CXCL1 in crosstalk between endocrine resistant breast cancer and fibroblastSneha Pandithar, Daniel Galke, Ahone Akume, et al.
Cancer Research|December 28, 2014
HOXB7 promotes malignant progression by activating the TGFβ signaling pathwayShou Liu, Kideok Jin, Yvonne Hui, et al.
Molecular Oncology|March 16, 2017
Inhibitors of STAT3, β-catenin, and IGF-1R sensitize mouse PIK3CA-mutant breast cancer to PI3K inhibitorsVanessa F Merino, Soonweng Cho, Xiaohui Liang, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
The Journal of Biological Chemistry|November 1, 2005
The survival kinase Mirk/dyrk1B is activated through Rac1-MKK3 signalingKideok Jin, Seunghwan Lim, Stephen E Mercer, et al.
Cancer Research|August 3, 2007
The survival kinase Mirk/Dyrk1B is a downstream effector of oncogenic K-ras in pancreatic cancerKideok Jin, Sunju Park, Daina Z Ewton, et al.
The Journal of Biological Chemistry|June 23, 2009
Mirk regulates the exit of colon cancer cells from quiescenceKideok Jin, Daina Z Ewton, Sunju Park, et al.
Experimental & Molecular Medicine|March 19, 2003
Metastasis-suppressor KAI1/CD82 induces homotypic aggregation of human prostate cancer cells through Src-dependent pathwayBokeun Jee, Kideok Jin, Jang-Hee Hahn, et al.
Nature Communications|September 3, 2014
Breast cancer cells condition lymphatic endothelial cells within pre-metastatic niches to promote metastasisEsak Lee, Elana J Fertig, Kideok Jin, et al.
The Journal of Biological Chemistry|June 12, 2002
The stress-activated protein kinases p38 alpha and JNK1 stabilize p21(Cip1) by phosphorylationGeum-Yi Kim, Stephen E Mercer, Daina Z Ewton, et al.
The Prostate|December 19, 2018
HOXB13 interaction with MEIS1 modifies proliferation and gene expression in prostate cancerDorhyun Johng, Gonzalo Torga, Charles M Ewing, et al.
Molecular Biology Reports|February 23, 2024
The role of CXCL1 in crosstalk between endocrine resistant breast cancer and fibroblastSneha Pandithar, Daniel Galke, Ahone Akume, et al.
Cancer Research|December 28, 2014
HOXB7 promotes malignant progression by activating the TGFβ signaling pathwayShou Liu, Kideok Jin, Yvonne Hui, et al.
Molecular Oncology|March 16, 2017
Inhibitors of STAT3, β-catenin, and IGF-1R sensitize mouse PIK3CA-mutant breast cancer to PI3K inhibitorsVanessa F Merino, Soonweng Cho, Xiaohui Liang, et al.
Pageof 3